Measurement properties of outcome measures for vitiligo: A systematic review

Archives of Dermatology

Volumn 148, Issue 11, 2012, Pages 1302-1309

  Vrijman, Charlotte ^a,d   Linthorst Homan, May W ^a   Limpens, Jacqueline ^a   Van Der Veen, Wietze ^a,b   Wolkerstorfer, Albert ^a   Terwee, Caroline B ^c   Spuls, Phyllis I ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Department of Epidemiology and Biostatistics EMGO Institute for Health and Care Research VU University Medical Centre ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CONSTRUCT VALIDITY; CONTENT VALIDITY; CRITERION RELATED VALIDITY; DERMATOLOGY LIFE QUALITY INDEX; DIGITAL IMAGE ANALYSIS SYSTEM; HUMAN; IMAGE ANALYSIS TECHNIQUE; INTERNAL CONSISTENCY; MEASUREMENT ERROR; OUTCOME ASSESSMENT; PATIENT BENEFIT INDEX; PICTORIAL REPRESENTATION OF ILLNESS MEASURE; POINT COUNTING; PRIORITY JOURNAL; RELIABILITY; REVIEW; SKINDEX 16; SKINDEX 29; SKINDEX TEEN; STRUCTURAL VALIDITY; SYSTEMATIC REVIEW; VALIDITY; VITILIGO; VITILIGO AREA SCORING INDEX; VITILIGO EUROPEAN TASK FORCE ASSESSMENT; CHECKLIST; QUALITY OF LIFE;

CHECKLIST; HUMANS; PATIENT OUTCOME ASSESSMENT; QUALITY OF LIFE; VITILIGO;

EID: 84869767237     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2012.3065     Document Type: Review

References (36)

1. Bigby M, Gadenne AS. Understanding and evaluating clinical trials. J Am Acad Dermatol. 1996;34(4):555-590.
2. Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539-549.
3. Schmitt J, Williams H; HOME Development Group. Harmonising Outcome Measures for Eczema (HOME): report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany. Br J Dermatol. 2010;163(6):1166-1168.
4. Naredo E, Wakefield RJ, Iagnocco A, et al. The OMERACT ultrasound task force - status and perspectives. J Rheumatol. 2011;38(9):2063-2067.
5. Spuls PI, Lecluse LL, Poulsen ML, Bos JD, Stern RS, Nijsten T. How good are clinical severity and outcome measures for psoriasis? quantitative evaluation in a systematic review. J Invest Dermatol. 2010;130(4):933-943.
6. Schmitt J, Langan S, Williams HC; European Dermato-Epidemiology Network. What are the best outcome measurements for atopic eczema? a systematic review. J Allergy Clin Immunol. 2007;120(6):1389-1398. (Pubitemid 350216596)
7. Schmitt J, Langan S, Stamm T, Williams HC; Harmonizing Outcome Measurements in Eczema (HOME) Delphi panel. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. J Invest Dermatol. 2011;131(3):623-630.
8. Schram ME, Spuls PI, Leeflang MM, Lindeboom R, Bos JD, Schmitt J. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness andminimal clinically important difference. Allergy. 2012;67(1):99-106.
9. Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res. 2012;21(4):651-657.
10. Mokkink LB, Terwee CB, Knol DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. 2010;10:22.
11. Whitton ME, Pinart M, Batchelor J, Lushey C, Leonardi-Bee J, González U. Interventions for vitiligo. Cochrane Database Syst Rev. 2010;(1):CD003263.
12. Taïeb A, Picardo M; VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007;20(1):27-35. (Pubitemid 46090162)
13. Terwee CB, Jansma EP, Riphagen II, de Vet HC. Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments. Qual Life Res. 2009;18(8):1115-1123.
14. Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737-745.
15. de Vet HC, Terluin B, Knol DL, et al. Three ways to quantify uncertainty in individually applied "minimally important change" values. J Clin Epidemiol. 2010;63(1):37-45.
16. de Vet HC, Terwee CB. The minimal detectable change should not replace the minimal important difference. J Clin Epidemiol. 2010;63(7):804-805.
17. Terwee CB, Roorda LD, Dekker J, et al. Mind the MIC: large variation among populations and methods. J Clin Epidemiol. 2010;63(5):524-534.
18. US Food and Drug Administration. Review and Qualification of Clinical Outcome Assessments; Public Workshop. http://www.fda.gov/Drugs/NewsEvents/ ucm276110.htm. Accessed November 2011.
19. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34-42. (Pubitemid 44856236)
20. van Tulder M, Furlan A, Bombardier C, Bouter L; Editorial Board of the Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine (Phila Pa 1976). 2003;28(12):1290-1299.
21. Jalel A, Soumaya GS, Hamdaoui MH. Dermatology life quality index scores in vitiligo: reliability and validity of the Tunisian version. Indian J Dermatol. 2009;54(4):330-333.
22. Aghaei S, Sodaifi M, Jafari P, Mazharinia N, Finlay AY. DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol. 2004;4:8.
23. Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol. 2004;140(6):677-683. (Pubitemid 38747282)
24. Aydin F, Senturk N, Sahin B, Bek Y, Yuksel EP, Turanli AY. A practical method for the estimation of vitiligo surface area: a comparison between the point counting and digital planimetry techniques. Eur J Dermatol. 2007;17(1):30-32. (Pubitemid 46383217)
25. Nijsten T, Sampogna F, Abeni D. Categorization of Skindex-29 scores usingmixture analysis. Dermatology. 2009;218(2):151-154.
26. Zghal A, Zeglaoui F, Kallel L, et al. Quality of life in dermatology: Tunisian version of the Skindex-29. Tunis Med. 2003;81(1):34-37. (Pubitemid 36427252)
27. AlGhamdi KM, AlShammari SA. Arabic version of Skindex-16: translation and cultural adaptation, with assessment of reliability and validity. Int J Dermatol. 2007;46(3):247-252.
28. Smidt AC, Lai J-S, Cella D, Patel S, Mancini AJ, Chamlin SL. Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease. Arch Dermatol. 2010;146(8):865-869.
29. Kent G, al-Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol. 1996;21(5):330-333. (Pubitemid 27075314)
30. Augustin M, Gajur AI, Reich C, Rustenbach SJ, Schaefer I. Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire. Dermatology. 2008;217(2):101-106.
31. Rumpf H-J, Löntz W, Uesseler S. A self-administered version of a brief measure of suffering: first aspects of validity. Psychother Psychosom. 2004;73(1):53-56. (Pubitemid 37524103)
32. Van Geel N, Vander Haeghen Y, Ongenae K, Naeyaert J-M. A new digital image analysis system useful for surface assessment of vitiligo lesions in transplantation studies. Eur J Dermatol. 2004;14(3):150-155. (Pubitemid 38738453)
33. Nugroho H, Fadzil MH, Yap VV, Norashikin S, Suraiya HH. Determination of skin repigmentation progression. Conf Proc IEEE Eng Med Biol Soc. 2007;2007:3442-3445.
34. Fadzil MH, Norashikin S, Suraiya HH, Nugroho H. Independent component analysis for assessing therapeutic response in vitiligo skin disorder. J Med Eng Technol. 2009;33(2):101-109.
35. Mokkink LB, Terwee CB, Gibbons E, et al. Inter-rater agreement and reliability of the COSMIN (COnsensus-based Standards for the selection of health status Measurement Instruments) checklist. BMC Med Res Methodol. 2010;10:82.
36. Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L. OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials. 2007;8:38.